In search of the fibrotic epithelial cell: Opportunities for a collaborative network

Thorax

Volumn 67, Issue 2, 2012, Pages 179-182

  Jenkins, Gisli ^a   Blanchard, Andrew ^b   Borok, Zea ^c   Bradding, Peter ^d   Ehrhardt, Carsten ^e   Fisher, Andrew ^f   Hirani, Nik ^g   Johnson, Simon ^a   Kon̈igshoff, Melanie ^h   Maher, Toby M ^i,j   Millar, Ann ^k   Parfrey, Helen ^l   Scotton, Chris ^j   Tetley, Terry ⁱ   Thickett, David ^m   Wolters, Paul ⁿ  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e TRINITY COLLEGE DUBLIN   (Ireland)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

^k SOUTHMEAD HOSPITAL   (United Kingdom)

^l UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^m UNIVERSITY OF BIRMINGHAM   (United Kingdom)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL DIVISION; CELL ISOLATION; CELL SELECTION; CELL VIABILITY; CRYOPRESERVATION; CULTURE TECHNIQUE; CYTOLOGY; FIBROSING ALVEOLITIS; GOVERNMENT REGULATION; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG BIOPSY; LUNG TRANSPLANTATION; NONHUMAN; NOTE; PRIORITY JOURNAL; VIDEO ASSISTED THORACOSCOPIC SURGERY;

EID: 84856034708     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2011-200195     Document Type: Article

References (36)

1. Navaratnam V, Fleming KM, West J, et al. The rising incidence of IPF in the UK. Thorax 2011;66:462-7.
2. Gribbin J, Hubbard RB, Le Jeune I, et al. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006;61:980-5. (Pubitemid 44787169)
3. Rudd RM, Prescott RJ, Chalmers JC, et al Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. British Thoracic Society study on cryptogenic fibrosing alveolitis: response to treatment and survival. Thorax 2007;62:62-6. (Pubitemid 46101768)
4. Demedts M, Behr J, Buhl R, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005;353:2229-42. (Pubitemid 41697286)
5. Taniguchi H, Ebina M, Kondoh Y, et al. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 2010;35:821-9.
6. Datta A, Scotton CJ, Chambers RC. Novel therapeutic approaches for pulmonary fibrosis. Br J Pharmacol 2011;163:141-72.
7. Eickelberg O, Laurent GJ. The quest for the initial lesion in idiopathic pulmonary fibrosis: gene expression differences in IPF fibroblasts. Am J Respir Cell Mol Biol 2010;42:1-2.
8. Strieter RM, Mehrad B. New mechanisms of pulmonary fibrosis. Chest 2009;136:1364-70.
9. Kasper M, Haroske G. Alterations in the alveolar epithelium after injury leading to pulmonary fibrosis. Histol Histopathol 1996;11:463-83. (Pubitemid 26135211)
10. Kawanami O, Ferrans VJ, Fulmer JD, et al. Nuclear inclusions in alveolar epithelium of patients with fibrotic lung disorders. Am J Pathol 1979;94:301-22. (Pubitemid 9114124)
11. Kawanami O, Ferrans VJ, Crystal RG. Structure of alveolar epithelial cells in patients with fibrotic lung disorders. Lab Invest 1982;46:39-53. (Pubitemid 12167015)
12. Basset F, Ferrans VJ, Soler P, et al. Intraluminal fibrosis in interstitial lung disorders. Am J Pathol 1986;122:443-61. (Pubitemid 16017665)
13. Coward WR, Saini G, Jenkins G. The pathogenesis of idiopathic pulmonary fibrosis. Ther Adv Respir Dis 2010;4:367-88.
14. Kon̈igshoff M, Eickelberg O. WNT signaling in lung disease: a failure or a regeneration signal? Am J Respir Cell Mol Biol 2010;42:21-31.
15. Margadant C, Sonnenberg A. Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep 2010;11:97-105.
16. Xu MY, Porte J, Knox AJ, et al. Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha (q). Am J Pathol 2009;174:1264-79.
17. Scotton CJ, Krupiczojc MA, Kon̈igshoff M, et al. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J Clin Invest 2009;119:2550-63.
18. Kon̈igshoff M, Kramer M, Balsara N, et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest 2009;119:772-87.
19. Liu G, Friggeri A, Yang Y, et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 2010;207:1589-97.
20. Zuo F, Kaminski N, Eugui E, et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci U S A 2002;99:6292-7. (Pubitemid 34493305)
21. Buckley ST, Medina C, Ehrhardt C. Differential susceptibility to epithelial-mesenchymal transition (EMT) of alveolar, bronchial and intestinal epithelial cells in vitro and the effect of angiotensin II receptor inhibition. Cell Tissue Res 2010;342:39-51.
22. Shaw RJ, Djukanovic R, Tashkin DP, et al. The role of small airways in lung disease. Respir Med 2002;96:67-80.
23. Tiitto LH, Peltoniemi MJ, Kaarteenaho-Wiik RL, et al. Cell-specific regulation of gamma-glutamylcysteine synthetase in human interstitial lung diseases. Hum Pathol 2004;35:832-9. (Pubitemid 38903076)
24. Birring SS, Parker D, McKenna S, et al. Sputum eosinophilia in idiopathic pulmonary fibrosis. Inflamm Res 2005;54:51-6. (Pubitemid 40585346)
25. Seibold MA, Wise AL, Speer MC, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 2011;364:1503-12.
26. Demling N, Ehrhardt C, Kasper M, et al. Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells. Cell Tissue Res 2006;323:475-88. (Pubitemid 43228103)
27. Marmai C, Sutherland RE, Kim KK, et al. Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2011. [Epub ahead of print] doi:10.1152/ajplung. 00212.2010.
28. Kikkawa Y, Yoneda K. The type II epithelial cell of the lung. I. Method of isolation. Lab Invest 1974;30:76-84.
29. Dobbs LG. Isolation and culture of alveolar type II cells. Am J Physiol 1990;258: L134-47. (Pubitemid 20145318)
30. Robinson PC, Voelker DR, Mason RJ. Isolation and culture of human alveolar type II epithelial cells. Characterization of their phospholipid secretion. Am Rev Respir Dis 1984;130:1156-60. (Pubitemid 15186182)
31. Bingle L, Bull TB, Fox B, et al. Type II pneumocytes in mixed cell culture of human lung: a light and electron microscopic study. Environ Health Perspect 1990;85:71-80. (Pubitemid 20315283)
32. Witherden IR, Vanden Bon EJ, Goldstraw P, et al. Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase. Am J Respir Cell Mol Biol 2004;30:500-9. (Pubitemid 38457183)
33. Ehrhardt C, Kim KJ, Lehr CM. Isolation and culture of human alveolar epithelial cells. Methods Mol Med 2005;107:207-16.
34. Witherden IR, Tetley TD. Isolation and culture of human alveolar type II pneumocytes. In: Rogers DF, Donnelly LE, eds. Human Airway Inflammation: Sampling Techniques and Analytical Protocols. Totowa, NJ: Humana Press Inc, 2001:137-41.
35. Maher TM, Evans IC, Bottoms SE, et al. Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2010;182:73-82.
36. Lindell KO, Erlen JA, Kaminski N. Lessons from our patients: development of a warm autopsy program. PLoS Med 2006;3:e234.